Welcome to our dedicated page for Veralto Corporation SEC filings (Ticker: VLTO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to Veralto Corporation’s (NYSE: VLTO) SEC filings, giving investors and researchers a structured view of the company’s regulatory disclosures. As a Delaware-incorporated public company listed on the New York Stock Exchange, Veralto files annual, quarterly and current reports that describe its financial performance, segment results and material corporate events.
Annual reports on Form 10‑K typically include detailed discussions of Veralto’s water quality and product quality and innovation segments, risk factors, segment-level sales information and broader business descriptions. Quarterly reports on Form 10‑Q update these disclosures with interim financial statements, management’s discussion and analysis, and recent developments affecting the business.
Current reports on Form 8‑K capture specific events such as quarterly earnings announcements, leadership changes and capital allocation decisions. Recent 8‑K filings have reported Veralto’s quarterly financial results, the authorization of a share repurchase program for up to $750 million of common stock, and executive transitions in the role of Senior Vice President and Chief Legal Officer. These filings often incorporate or reference related press releases as exhibits.
Investors interested in insider activity can review Forms 3, 4 and 5, which report beneficial ownership and changes in holdings by directors, officers and other insiders. Proxy statements and related documents provide additional detail on executive compensation, governance structures and board composition.
On Stock Titan, Veralto’s filings are supplemented with AI-powered summaries that highlight key points from lengthy documents such as 10‑K and 10‑Q reports. These summaries are designed to help users quickly understand segment performance, major risk disclosures, capital allocation decisions and other material items without reading every page. Real-time updates from the SEC’s EDGAR system ensure that new Veralto filings, including Form 4 insider transactions and 8‑K current reports, appear promptly with concise explanations of their significance.
Veralto Corp reports that Vanguard Capital Management holds 18,153,412 shares of Common Stock, representing 7.39% of the class. The filing states Vanguard has 2,446,963 shares of sole voting power and 18,153,412 shares of sole dispositive power. The report is signed by Ashley Grim on 04/30/2026.
Veralto Corporation reported stronger results for the three months ended April 3, 2026. Sales reached $1.422 billion, up 6.7%, with core sales growing 1.9% and price contributing 1.9 percentage points. Net earnings increased to $254 million, and diluted EPS rose to $1.02 from $0.90.
Water Quality led growth with sales of $874 million, up 10.1% (3.8% core), while Product Quality & Innovation sales were $548 million, up 1.7% but with a 1.0% core decline. Recurring revenue represented about 62% of total sales, supporting margins and cash flow.
Veralto completed the $426 million cash acquisition of In‑Situ in Water Quality and, after quarter‑end, agreed to acquire GlobalVision for CAD $270 million for PQI. It repurchased roughly 3 million shares for about $300 million, leaving $450 million under its authorization. Operating cash flow was $182 million, while heavy acquisition and buyback spending reduced cash to $1.431 billion. The Board also approved a 2026 Restructuring Program expected to generate $85–$105 million of charges through 2028 to simplify operations and optimize costs.
Veralto Corporation reported higher results for the first quarter of 2026. Sales rose 6.7% year-over-year to $1,422 million, with non-GAAP core sales growth of 1.9%. Operating profit margin was 23.8%, and adjusted operating profit margin was 25.1%.
Net earnings were $254 million, or $1.02 per diluted share, while adjusted net earnings were $266 million, or $1.07 per diluted share. Operating cash flow reached $182 million and non-GAAP free cash flow was $170 million.
Year-to-date capital allocation was about $1 billion, including approximately $620 million for the In-Situ and GlobalVision acquisitions and $300 million of share repurchases, equal to 1.3% of outstanding shares as of February 13, 2026. Veralto also launched a cost optimization program expected to incur charges of $85 to $105 million and deliver annual savings of $65 to $75 million by 2028. The company raised its 2026 adjusted EPS outlook to $4.20–$4.28 and now targets free cash flow conversion of about 100% of GAAP net earnings.
VLTO notice of proposed sale under Rule 144 for 10,000 shares held at Fidelity Brokerage Services LLC, dated 03/30/2026. The filing cites an option granted on 07/15/2023 as the source of the shares. It also lists a recent sale of 8,664 shares on 03/12/2026.
Veralto Corp disclosure: The Vanguard Group filed Amendment No. 4 to a Schedule 13G/A reporting 0 shares beneficially owned and 0% of Veralto Corp common stock. The filing explains an internal realignment on January 12, 2026 and states certain Vanguard subsidiaries will report separately in reliance on SEC Release No. 34-39538.
Veralto Corporation reported a strong 2025 driven by record revenue and cash generation. Total sales reached $5.5 billion, adjusted EPS was $3.90 (an increase of 10%), and free cash flow exceeded $1 billion. The company increased its dividend by 18% and authorized a $750 million share repurchase program while reporting $2.673 billion of total debt. Veralto described broad‑based growth across its two segments — Water Quality ($3.3B) and Product Quality & Innovation ($2.2B) — and reiterated expectations for continued core sales, margin and adjusted EPS growth in 2026.
Veralto Corporation is asking shareholders to vote at its 2026 virtual annual meeting on director elections, auditor ratification and an advisory say-on-pay resolution. Four Class III directors, including the CEO and independent chair, are nominated for one-year terms as part of a phased Board declassification.
The Board highlights strong 2025 performance with approximately $5.5 billion in revenue, core sales growth, margin expansion, double-digit adjusted EPS growth and robust cash flow, supported by the Veralto Enterprise System and increased growth investments.
Veralto emphasizes governance and sustainability, including an independent chair, fully independent key committees, elimination of supermajority voting, annual say-on-pay, pay-for-performance with most executive pay at risk, rigorous clawback and anti-hedging policies, climate and human capital goals, and a commitment to equal pay globally by 2030.
Trivedi Surekha reported acquisition or exercise transactions in this Form 4 filing.
Veralto Corp reported that SVP of Strategy & Sustainability Surekha Trivedi received new equity awards on March 1, 2026. She was granted 7,824 employee stock options and 2,310 shares of common stock through restricted stock units. The RSUs and options vest in two equal parts on the third and fourth anniversaries of the grant date, tying her compensation to Veralto’s long-term performance.
Veralto Corp Chief Accounting Officer Bernard M. Skeete reported equity awards and a small tax-related share disposition. On March 1, 2026, he received an employee stock option grant for 4,637 options at a price of $0.00 and a grant of 1,369 shares of common stock payable under restricted stock units.
According to the footnotes, one quarter of both the options and RSUs vest on each of the first, second, third, and fourth anniversaries of the March 1, 2026 grant date. On February 27, 2026, 103 shares of common stock were disposed of at $97.43 per share to satisfy tax obligations through a tax-withholding transaction, leaving 3,691 shares of common stock directly owned after that disposition and 5,060 shares following the later RSU grant.